pharma news today glp-1 Giants Bet on Next-Generation Treatments to Sustain Growth GLP-1 Patents Are Fading -

Weight Loss: While weight loss can be a desirable outcome for many individuals with type 2 diabetes, excessive weight loss associated with GLP-1 medications may be problematic for some patients, especially those who are already at a healthy weight or at risk of malnutrition

Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1

Interventions primarily include drugs like metformin and GLP-1RAs (e.g., liraglutide), with some combining drugs for enhanced effectiveness

Due to risks for diminished therapeutic effects of oral birth control pills, the manufacturer of Bydureon (exenatide) recommends taking birth control at least one hour prior to exenatide

Russell-Jones D, Vaag A, Schmitz O, Sethi BK, Lalic N, Antic S, Zdravkovic M, Ravn GM, Sim R

Semaglutide GLP-1 injections for weight loss are not recommended for use on patients who also have been diagnosed with type 1 diabetes, decreased kidney function or kidney disease, medullary thyroid cancer, or disease of the gallbladder